Correlation Between Catalyst Pharmaceuticals and 90331HPL1

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and 90331HPL1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and 90331HPL1 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and US BANK NATIONAL, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and 90331HPL1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of 90331HPL1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and 90331HPL1.

Diversification Opportunities for Catalyst Pharmaceuticals and 90331HPL1

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Catalyst and 90331HPL1 is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and US BANK NATIONAL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US BANK NATIONAL and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with 90331HPL1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US BANK NATIONAL has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and 90331HPL1 go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and 90331HPL1

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 2.17 times more return on investment than 90331HPL1. However, Catalyst Pharmaceuticals is 2.17 times more volatile than US BANK NATIONAL. It trades about 0.14 of its potential returns per unit of risk. US BANK NATIONAL is currently generating about -0.07 per unit of risk. If you would invest  1,988  in Catalyst Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  219.00  from holding Catalyst Pharmaceuticals or generate 11.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy64.29%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  US BANK NATIONAL

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
US BANK NATIONAL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US BANK NATIONAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 90331HPL1 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Catalyst Pharmaceuticals and 90331HPL1 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and 90331HPL1

The main advantage of trading using opposite Catalyst Pharmaceuticals and 90331HPL1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, 90331HPL1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 90331HPL1 will offset losses from the drop in 90331HPL1's long position.
The idea behind Catalyst Pharmaceuticals and US BANK NATIONAL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals